Reports Q3 revenue $29.47M, consensus $29.06M. System-wide comp sales for clinics that have been open for at least 13 full months were flat. “The strength of our franchise concept to revolutionize access to chiropractic care remains strong, although ongoing economic uncertainty and continued cost pressures have impacted our corporate clinic portfolio performance. We are implementing a strategic plan to leverage our greatest strength – our capacity to build a franchise – to drive long-term growth for both our franchisees and The Joint as a public company,” said Peter D. Holt, President and Chief Executive Officer of The Joint Corp. “After evaluating options for improvement, the board has authorized management to initiate a plan to refranchise or sell the majority of our company-owned or managed clinics and to retain a portion of the high-performing corporate clinics. With a focus on profitability, we are taking clear action to strengthen the health of our franchise network and increase our ability to reinvest in the business to create value for our stakeholders.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on JYNT:
- Joint Corp. names Jeff Gramm to board, signs standstill agreement with Bandera
- The Joint Corp. Welcomes Jeff Gramm to the Board of Directors and Signs Standstill Agreement with Bandera Partners LLC
- JYNT Earnings this Week: How Will it Perform?
- The Joint Corp. to Host Conference Call on Thursday, November 9th to Discuss Third Quarter 2023 Results
- Joint Corp. resumed with a Hold at Craig-Hallum